|This Slide: #85 of 100|
Slide #85. Perrigo Company plc — OTC Products In Australia
Perrigo Company plc (NYSE:PRGO)
OTC Products In Australia
Perrigo Company plc (NYSE: PRGO;TASE) announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc. for $51 million in cash. The products are primarily sold through the mass retail channel and include the Herron range of analgesics, vitamins and supplements. This basket of products is expected to generate at least $20 million in annual revenue.
Perrigo is a global healthcare company. Co. is a producer of generic pharmaceutical topical products such as creams, lotions, gels, and nasal sprays. Co.'s segments are: Consumer Healthcare Americas, which provides products for analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritionals, smoking cessation, animal health, vitamins, minerals and dietary supplements, and other miscellaneous healthcare products; Consumer Healthcare International, which provides products for cough, cold, allergy, sinus, personal care and derma-therapeutics, and anti-parasite; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
Perrigo SEC Filing Email Alerts Service
Open the PRGO Page at The Online Investor »
Hold (2.18 out of 4)
(ranked lower than approx. 94% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite